GSK vs NKE · P/E 13, $103.31B cap vs P/E 35, rev $46.40B
GlaxoSmithKline PLC ADR (GSK) versus Nike Inc (NKE) — a side-by-side from cached financials, not a winner call.
GlaxoSmithKline PLC ADR (GSK) is a drug manufacturers - general company listed on US.
Nike Inc (NKE) is a footwear & accessories company listed on US. It is led by Elliott J. Hill.
GSK does not have a complete income-statement cache yet.
Latest reported NKE revenue for 2026-05-31 was $46.40B. Net income was $3.11B. NKE currently screens at market cap $110.14B and trailing P/E 34.6.
GSK currently screens at market cap $103.31B and trailing P/E 13.5. NKE currently screens at market cap $110.14B and trailing P/E 34.6.
Not investment advice. Open the GSK and NKE stock pages for the full models.
Not investment advice.